KRAS and non-small cell lung carcinoma: Inhibition of tumor growth in human non-small cell lung cancer xenografts and the KRAS-G12D transgenic mouse model have resulted from therapeutic delivery of let-7 in either the form of a let-7 mimic or a virus [34].